Hepatic STAT5 deficiency exacerbated hyperglycemia and dyslipidemia [37] and liver-specific STAT6 deletion directly mediated hepatic steatosis and insulin resistance [38]. The gene discussed is STAT6; the disease is metabolic syndrome.